Now it’s the reason he’s famous. The thing about family, Josh Johnson wants me to know, as he scoots closer and angles his phone in my direction, is that they suck at boundaries. It’s ...
What will Speaker Mike Johnson (R-La.) do? That’s the quiet question bouncing around Washington this month as the parties race furiously toward Election Day — when both the House and White Hou ...
Johnson & Johnson filed a third chapter 11 case on Friday seeking to resolve mass lawsuits linking its cosmetic talc products to cancer. Opponents are already questioning the filing, aiming to ...
House Speaker Mike Johnson laid out the next plans to avert a government shutdown in a Sunday letter to his members. Johnson’s plan, known as a limited continuing resolution, would fund the ...
Johnson & Johnson’s hopes to use a bankruptcy filing to resolve one of the largest-ever mass torts could depend on the outcome of a professional feud between two Southern lawyers who each claim ...
Speaker Mike Johnson (R-La.) is promising that the House will not approve a single, massive bill to fund the entire government in December — a scenario feared by conservatives — despite a ...
Johnson still smiles for the cameras, but his future as a speaker is uncertain. Rank-and-file Republicans say he’s not a fighter like those running atop the GOP ticket this fall. “The public ...
Mike Johnson won 341 votes for his final stopgap spending plan Wednesday evening, but his strategy ultimately had an audience of just one person: Donald Trump. After nearly a year of leading the ...
The House on Wednesday voted down Speaker Mike Johnson's government funding plan with 14 Republicans voting against it and two others voting present. The measure failed by a 202-222-2 margin.
Speaker Mike Johnson has set up a Wednesday vote on a six-month GOP government funding plan that is expected to fail, as the Louisiana Republican is under pressure to show the bill cannot pass ...
Johnson & Johnson's stock has seen modest gains in recent months, supported by approvals for treatments like Tremfya, Darzalex Faspro, and Rybrevant. Despite positive developments, litigation ...
Two Republicans voted present. Even with a Sept. 30 deadline approaching to fund the government, Mr. Johnson had pulled the plug on the vote last week as it became apparent that his plan would not ...